Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cancer Research|April 1, 1986
Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in cultureB K Bhuyan, E G Adams, G J Badiner, et al.Journal of Virology|September 1, 1990
Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteinsJ A Nicholas, K L Rubino, M E Levely, et al.Cancer Research|October 15, 1992
Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cellsB K Bhuyan, K S Smith, E G Adams, et al.In Vitro|August 1, 1981
Changes in DNA distributions and ploidy of CHO cells as a function of time in cultureS C Barranco, K Shilkun, S Nichols, et al.Cancer Research|March 15, 1993
Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesinB K Bhuyan, K S Smith, R C Kelly, et al.Cancer Research|May 1, 1984
Biochemical and cellular effects of didemnins A and BS L Crampton, E G Adams, S L Kuentzel, et al.Immunopharmacology|December 1, 1982
Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levelsP E Fast, C A Hatfield, C L Franz, et al.Human Molecular Genetics|August 1, 1996
Differential expression of dystrophin isoforms in strains of mdx mice with different mutationsW B Im, S F Phelps, E H Copen, et al.Selective Cancer Therapeutics|January 1, 1990
HPLC and flow cytometric analyses of uptake of adriamycin and menogaril by monolayers and multicell spheroidsT J Bichay, E G Adams, W R Inch, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effectsB K Bhuyan, K S Smith, E G Adams, et al.Pageof 3